April 22, 2008 - The Sorin Group received the Japanese Pharmaceutical and Medical Devices Agency's (PMDA) approval to market its Stockert S5 Heart-Lung Machine in Japan, an important milestone for a company trying to gain market leadership in heart-lung machines in Japan and consolidate a leading worldwide market share.
The Stockert S5 is the fifth-generation of heart-lung machine has a smaller footprint for the S5 to allow closer positioning of the unit to the patient, designed to reduce line lengths and the possibility of hemodilution.
Acoustically differentiated alarms and information displayed on the high-resolution touch screens describe the status of all monitoring functions of the extracorporeal circuit. According to the manufacturer, the S5 has no boot-up time so that the pumps are operable three seconds after turning the system on, which is extremely important in emergency situations.
For more information: www.sorin.com